Gene and Cell Therapy – Webinars and Online Events

In this webinar, our expert speakers will explore the vital role of qPCR and digital PCR in supporting advanced therapy medicinal products, including cell therapies. Discover best practices for assay design, validation parameters and acceptance criteria crucial for ensuring the safety and efficacy of cell therapy programs. Learn how molecular precision can safeguard these innovative therapies and drive breakthroughs in the field.

In this webinar, you will learn about the OGM workflow and how it can be applied to cell and gene therapy R&D, with emphasis on how it can significantly improve the quality, safety and overall risk profile of next-generation therapies.

To support the development of mRNA-based therapies scientists require platforms that will help to address the selectivity and capacity requirements for the large-scale manufacturing of mRNA used in vaccine and gene therapy applications.

There are hundreds of drug candidates to screen for purity, integrity and stability during early drug development, which can become a considerable bottleneck.

To adequately assess the safety and efficacy of candidate gene therapies, robust bioanalytical technologies must support regulated studies. Hence, many labs now incorporate the latest qPCR and digital PCR (dPCR) methods into their preclinical and clinical development workflows to assure data accuracy and product effectiveness.

This webinar highlights the latest ways to maximize productivity in your AAV manufacturing workflow using affinity chromatography methods.

This webinar highlights the latest affinity chromatography solutions for the quick and easy purification of multiple AAV serotypes across a variety of column setups.

Unleash the potential of genetic analysis technologies in gene therapy development. Join this webinar to explore the scientific advancements and breakthroughs made possible by analytical methods. Discover how these technologies overcome challenges, enabling critical product characterization, safety and regulatory compliance.

Human induced pluripotent stem cells (iPSC) can renew almost indefinitely and differentiate to any adult cell in the body thus making them ideal materials for developing new cell-based therapies. The efficacy and manufacturability of these therapies critically rely on reagents such as media and surface substrates used during iPSC expansion and differentiation outcomes.

Speaking at Cell & Gene Therapy 2023, Dr. Gabriella Perell and Dr. Xi Lu from Bio-Techne, presented their talk on Biotechne’s portfolio of cGMP and animal-free reagents including iPSC expansion media, vitronectin culture substrates, small molecules, and growth factors. Dr, Perell and Dr. Lu will demonstrate the application of these reagents towards establishing an iPSC to iNK workflow.

Speaking at Cell & Gene Therapy 2023,Tracy Zhao from ACROBiosystems, presented their talk on products and services across cell therapy research and development.